JP2024516655A5 - - Google Patents
Info
- Publication number
- JP2024516655A5 JP2024516655A5 JP2023565998A JP2023565998A JP2024516655A5 JP 2024516655 A5 JP2024516655 A5 JP 2024516655A5 JP 2023565998 A JP2023565998 A JP 2023565998A JP 2023565998 A JP2023565998 A JP 2023565998A JP 2024516655 A5 JP2024516655 A5 JP 2024516655A5
- Authority
- JP
- Japan
- Prior art keywords
- lentiviral vector
- sequence
- rheam
- agxt
- vector according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21382363.6 | 2021-04-26 | ||
| EP21382363.6A EP4083217A1 (en) | 2021-04-26 | 2021-04-26 | In vivo lentiviral gene therapy for the treatment of primary hyperoxaluria type 1 |
| PCT/EP2022/061107 WO2022229223A1 (en) | 2021-04-26 | 2022-04-26 | In vivo lentiviral gene therapy for the treatment of primary hyperoxaluria type 1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516655A JP2024516655A (ja) | 2024-04-16 |
| JP2024516655A5 true JP2024516655A5 (enExample) | 2025-05-09 |
Family
ID=75746556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565998A Pending JP2024516655A (ja) | 2021-04-26 | 2022-04-26 | 原発性高シュウ酸尿症１型の治療のためのｉｎ ｖｉｖｏレンチウイルス遺伝子療法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP4083217A1 (enExample) |
| JP (1) | JP2024516655A (enExample) |
| KR (1) | KR20240004627A (enExample) |
| CN (1) | CN117561336A (enExample) |
| AU (1) | AU2022266057A1 (enExample) |
| CA (1) | CA3218031A1 (enExample) |
| MX (1) | MX2023012684A (enExample) |
| WO (1) | WO2022229223A1 (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2384200B1 (en) * | 2009-01-30 | 2013-07-10 | UniQure IP B.V. | Alanine-glyoxylate aminotransferase therapeutics |
| WO2015059701A1 (en) * | 2013-10-24 | 2015-04-30 | Medgenics Medical Israel Ltd. | Micro-organs providing sustained delivery of a therapeutic polypeptide and methods of use thereof |
| US11008561B2 (en) * | 2014-06-30 | 2021-05-18 | Bioverativ Therapeutics Inc. | Optimized factor IX gene |
| US11976293B2 (en) * | 2016-12-05 | 2024-05-07 | The Regents Of The University Of California | Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathies |
| US20210038744A1 (en) * | 2018-02-01 | 2021-02-11 | Bioverativ Therapeutics Inc. | Use of lentiviral vectors expressing factor viii |
-
2021
- 2021-04-26 EP EP21382363.6A patent/EP4083217A1/en not_active Withdrawn
-
2022
- 2022-04-26 CN CN202280045601.7A patent/CN117561336A/zh active Pending
- 2022-04-26 KR KR1020237040673A patent/KR20240004627A/ko active Pending
- 2022-04-26 EP EP22718999.0A patent/EP4330415A1/en not_active Withdrawn
- 2022-04-26 JP JP2023565998A patent/JP2024516655A/ja active Pending
- 2022-04-26 MX MX2023012684A patent/MX2023012684A/es unknown
- 2022-04-26 WO PCT/EP2022/061107 patent/WO2022229223A1/en not_active Ceased
- 2022-04-26 CA CA3218031A patent/CA3218031A1/en active Pending
- 2022-04-26 AU AU2022266057A patent/AU2022266057A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7340471B6 (ja) | ウイルスベクター産生系 | |
| Poeschla et al. | Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors | |
| JP5749014B2 (ja) | ポリプリントラクト改変レトロウイルスベクター | |
| JP7787064B2 (ja) | レンチウイルスベクターの製造の増強 | |
| JP7759318B2 (ja) | 産生系 | |
| EP1054988A1 (en) | Anti-viral vectors | |
| AU2009202763A1 (en) | Double-stranded nucleic acid | |
| US12344857B2 (en) | Viral vector production | |
| CN115667534A (zh) | 慢病毒载体 | |
| US9932597B2 (en) | Vectors for transgene expression | |
| JP2024536908A5 (enExample) | ||
| EP4530355A2 (en) | Lentiviral vectors | |
| EP1192265A1 (en) | Anti-viral vectors | |
| Mautino et al. | Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNA | |
| US20230220417A1 (en) | Lentiviral System | |
| TW202536176A (zh) | 用於增加ｕｂｅ３ａ之表現的方法和組成物 | |
| Pistello et al. | Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes | |
| JP2024520797A5 (enExample) | ||
| EP4274900A1 (en) | Tightly-regulated inducible expression system for production of biologics using stable cell lines | |
| Nurminsky | Two subfamilies of MDG1 retrotransposon with different evolutionary histories in D. melanogaster | |
| WO2025158155A1 (en) | Retroviral vectors | |
| WO2024031060A1 (en) | Lentiviral vectors and uses thereof | |
| MX2023012684A (es) | Terapia con gen lentiviral in vivo para el tratamiento de hiperoxaluria primaria tipo 1. | |
| Izmailova et al. | Functional analysis of the murine sarcoma virus RNA packaging sequence | |
| WO2000006760A1 (en) | Use of constitutive transport elements for host range control |